Lytix Biopharma ASA Balance Sheet

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	57.79	10.6	130.79	27.37	94.55	197.28
Short-Term Investments	62.39	-	-	23.18	50.61	-
Trading Asset Securities	-	61.76	-	-	-	-
Cash & Short-Term Investments	120.17	72.36	130.79	50.55	145.16	197.28
Cash Growth	1.93%	-44.68%	158.75%	-65.18%	-26.42%	593.43%
Accounts Receivable	-	0.35	0.46	-	-	-
Other Receivables	6.73	5.81	12.1	12.12	6	5.13
Receivables	6.73	6.15	12.56	12.12	6	5.13
Prepaid Expenses	-	0.93	0.55	0.66	0.74	0.55
Other Current Assets	-	-	-	0	-	-
Total Current Assets	126.9	79.44	143.9	63.33	151.89	202.96
Property, Plant & Equipment	1.9	2.09	2.63	0.55	1.38	2.14
Other Long-Term Assets	0	0	-	-	0	-
Total Assets	128.8	81.52	146.54	63.87	153.27	205.1
Accounts Payable	4.49	6.38	5.02	3.57	7	1.48
Accrued Expenses	-	6.21	24.44	2.38	2.11	3.77
Current Portion of Leases	1.02	0.98	0.76	0.45	0.87	0.83
Current Income Taxes Payable	-	1.07	1.19	1.36	0.95	2.03
Other Current Liabilities	7.84	3.92	5.36	4.74	6.83	6.06
Total Current Liabilities	13.35	18.55	36.76	12.51	17.76	14.17
Long-Term Leases	0.99	1.22	1.88	0.04	0.48	1.34
Other Long-Term Liabilities	-	-	-0	-	-	-
Total Liabilities	14.34	19.77	38.64	12.56	18.24	15.51
Common Stock	7.69	6.83	6.82	4.01	4.01	3.87
Additional Paid-In Capital	106.77	54.92	101.08	47.31	131.03	185.72
Comprehensive Income & Other	-	0	-	-	-	-0
Shareholders' Equity	114.46	61.75	107.89	51.32	135.03	189.59
Total Liabilities & Equity	128.8	81.52	146.54	63.87	153.27	205.1
Total Debt	2.02	2.2	2.64	0.49	1.34	2.17
Net Cash (Debt)	118.16	70.16	128.15	50.06	143.81	195.11
Net Cash Growth	2.73%	-45.25%	156.01%	-65.19%	-26.29%	585.80%
Net Cash Per Share	-	1.03	2.37	1.25	3.63	5.88
Filing Date Shares Outstanding	-	68.26	68.26	40.07	40.07	40.07
Total Common Shares Outstanding	-	68.26	68.16	40.07	40.07	38.74
Working Capital	113.55	60.88	107.14	50.81	134.13	188.8
Book Value Per Share	-	0.90	1.58	1.28	3.37	4.89
Tangible Book Value	114.46	61.75	107.89	51.32	135.03	189.59
Tangible Book Value Per Share	-	0.90	1.58	1.28	3.37	4.89
Machinery	-	0.2	0.2	0.2	0.15	-